Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Corvus Pharmaceuticals Inc buy Oppenheimer Holdings Inc.

Start price
€1.81
17.08.23 / 50%
Target price
-
17.08.24
Performance (%)
4.75%
Price
€1.90
14.05.24
Summary
This prediction is currently active. The BUY prediction by Oppenheimer_Holdings shows slight gains of 4.75%. This prediction currently runs until 17.08.24. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Corvus Pharmaceuticals Inc 7.605% 7.605%
iShares Core DAX® 1.662% 4.835%
iShares Nasdaq 100 0.667% 0.000%
iShares Nikkei 225® -2.139% -4.786%
iShares S&P 500 0.564% 0.775%

Comments by Oppenheimer_Holdings for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat

Stopped prediction by Oppenheimer_Holdings for Corvus Pharmaceuticals Inc

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.65
07.05.24
€7.42
07.05.25
14.91%
14.05.24

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.67
20.03.24
€6.45
20.03.25
24.85%
14.05.24